drugset / Trial / NCT02521714
Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension
RandomizedCrossoverOpen-labelOther
Summary
This study will evaluate the amount of drug that reaches the circulation when a subject takes the test (liquid) formulation compared to the reference (capsule) formulation. The study will also examine the effect of a high fat meal on the levels of drug in blood.
Timeline
- Start
- 2015-08-14
- Primary completion
- 2015-09-23
- Completion
- 2015-09-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lenalidomide | Other / unclassified | 25 mg | Oral |
Indications
No indication recorded.